SWAN-GANZ CCOMBO V CCO/SVO2/CEDV THERMODILUTION CATHETER 774F75

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-04-03 for SWAN-GANZ CCOMBO V CCO/SVO2/CEDV THERMODILUTION CATHETER 774F75 manufactured by Edwards Lifesciences, Pr.

Event Text Entries

[140913583] Our product evaluation laboratory received one model 774f75 catheter with a 1. 5cc syringe. The balloon was found to be ruptured around the circumference in the central area of the balloon latex. The latex edges did not seem to match at the ruptured region. All through lumens were patent without any leakage or occlusion. No other visible damage was observed from the catheter body. A device history record review was completed and documented that the device met all specifications upon distribution. The customer report of a balloon issue was confirmed on evaluation. An engineering evaluation has been initiated to assess for any manufacturing-related processes which could be correlated to the complaint. Invasive procedures involve some patient risks. Although serious complications are relatively uncommon, the physician is advised, before deciding to insert or use the catheter, to consider the potential benefits in relation to the possible complications. The techniques for insertion, methods of using the catheter to obtain patient data information, and the occurrence of complications is well described in the literature. It is standard practice to check balloon integrity by inflating it to the recommended volume in order to detect any asymmetry or leakage condition before use of the catheter. When there is separation of the balloon or fragments from the pulmonary artery catheter, the retained fragment will embolize to the lungs. Due to the large surface area of the pulmonary vasculature, this is generally well tolerated, but can lead to complications such as infection or small infarction. Pulmonary complications may result from improper inflation technique. To avoid damage to the pulmonary artery and possible balloon rupture, the balloon should not be inflated above the recommended volume. Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.
Patient Sequence No: 1, Text Type: N, H10


[140913584] It was reported that prior to insertion, the balloon on a swan-ganz catheter burst. A new device was used without issue. There was no patient injury. Patient demographics were requested and are unknown.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2015691-2019-01168
MDR Report Key8481163
Date Received2019-04-03
Date of Report2019-02-26
Date of Event2019-02-24
Date Mfgr Received2019-03-31
Device Manufacturer Date2018-03-09
Date Added to Maude2019-04-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. SAMANTHA EVELEIGH
Manufacturer StreetONE EDWARDS WAY
Manufacturer CityIRVINE CA 92614
Manufacturer CountryUS
Manufacturer Postal92614
Manufacturer Phone9492503939
Manufacturer G1EDWARDS LIFESCIENCES, PR
Manufacturer StreetSTATE RD INDUS PK 402 KM 1.4
Manufacturer CityANASCO PR 00610
Manufacturer CountryUS
Manufacturer Postal Code00610
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameSWAN-GANZ CCOMBO V CCO/SVO2/CEDV THERMODILUTION CATHETER
Generic NameCATHETER, OXIMETER, FIBEROPTIC
Product CodeDQE
Date Received2019-04-03
Returned To Mfg2019-03-28
Model Number774F75
Catalog Number774F75
Lot Number61286357
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerEDWARDS LIFESCIENCES, PR
Manufacturer AddressSTATE RD INDUS PK 402 KM 1.4 ANASCO PR 00610 US 00610


Patients

Patient NumberTreatmentOutcomeDate
10 2019-04-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.